Profilaktyka przedekspozycyjna HIV (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Profilaktyka przedekspozycyjna HIV" in Polish language version.

refsWebsite

Global rank Polish rank

10nih.gov

4^th place

7^th place

8doi.org

2^nd place

6^th place

8worldcat.org

5^th place

2^nd place

2who.int

195^th place

256^th place

2cdc.gov

218^th place

561^st place

2prep.edu.pl

low place

2fda.gov

447^th place

1,118^th place

2mp.pl

8,738^th place

165^th place

1web.archive.org

1^st place

1skaids.org

low place

1ptnaids.pl

low place

1hiv-aids.edu.pl

low place

1nyc.gov

1,074^th place

2,755^th place

1drugs.com

399^th place

2,234^th place

1ktomalek.pl

low place

1medme.pl

low place

2,542^nd place

1gaystarnews.com

6,135^th place

low place

1poz.com

low place

1afao.org.au

low place

11news.co.nz

low place

1aidsmap.com

low place

1starobserver.com.au

low place

1eurosurveillance.org

low place

1treated.com

low place

1thesocialmedwork.com

low place

1news.co.nz

HIV prevention drug Truvada to be publicly funded in New Zealand [online], 1 News [dostęp 2022-03-15] (ang.).

afao.org.au

admin, Pre-exposure prophylaxis (PrEP) [online], Australian Federation of AIDS Organisations [dostęp 2022-03-15] (ang.).

aidsmap.com

European PrEP programmes face two big issues: how to get more people coming forward, and how to serve them if they do [online], aidsmap.com [dostęp 2022-03-15] (ang.).

cdc.gov

US Public HealthU.P.H. Service US Public HealthU.P.H., PREEXPOSURE PROPHYLAXIS Preexposure prophylaxis for the prevention of HIV infection in the United States - 2014. A clinical practice guideline [online], 2014, s. 12 [zarchiwizowane z adresu 2018-04-11] .
Effective HIV Prevention Strategies | HIV Risk and Prevention Estimates | HIV Risk and Prevention | HIV/AIDS | CDC [online], www.cdc.gov, 8 grudnia 2021 [dostęp 2022-03-14] (ang.).

doi.org

dx.doi.org

Lisa A.L.A. Grohskopf Lisa A.L.A. i inni, Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States, „Journal of Acquired Immune Deficiency Syndromes (1999)”, 64 (1), 2013, s. 79–86, DOI: 10.1097/QAI.0b013e31828ece33, ISSN 1944-7884, PMID: 23466649 [dostęp 2022-03-14] .
Robert M.R.M. Grant Robert M.R.M. i inni, Preexposure chemoprophylaxis for HIV prevention in men who have sex with men, „The New England Journal of Medicine”, 363 (27), 2010, s. 2587–2599, DOI: 10.1056/NEJMoa1011205, ISSN 1533-4406, PMID: 21091279, PMCID: PMC3079639 [dostęp 2022-03-14] .
KachitK. Choopanya KachitK. i inni, Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial, „The Lancet”, 381 (9883), 2013, s. 2083–2090, DOI: 10.1016/S0140-6736(13)61127-7, ISSN 1474-547X, PMID: 23769234 [dostęp 2022-03-14] .
Jared M.J.M. Baeten Jared M.J.M. i inni, Antiretroviral Prophylaxis for HIV-1 Prevention among Heterosexual Men and Women, „The New England journal of medicine”, 367 (5), 2012, s. 399–410, DOI: 10.1056/NEJMoa1108524, ISSN 0028-4793, PMID: 22784037, PMCID: PMC3770474 [dostęp 2022-03-14] .
Michael C.M.C. Thigpen Michael C.M.C. i inni, Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana, „The New England Journal of Medicine”, 367 (5), 2012, s. 423–434, DOI: 10.1056/NEJMoa1110711, ISSN 0028-4793, PMID: 22784038 [dostęp 2022-03-14] .
Jared M.J.M. Baeten Jared M.J.M. i inni, Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial, „The Lancet. Infectious Diseases”, 14 (11), 2014, s. 1055–1064, DOI: 10.1016/S1473-3099(14)70937-5, ISSN 1474-4457, PMID: 25300863, PMCID: PMC4252589 [dostęp 2022-03-14] .
JamesJ. Wilton JamesJ. i inni, Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review, „HIV/AIDS (Auckland, N.Z.)”, 7, 2015, s. 125–136, DOI: 10.2147/HIV.S50025, ISSN 1179-1373, PMID: 25987851, PMCID: PMC4422285 [dostęp 2022-03-14] .
RosalieR. Hayes RosalieR. i inni, Estimating the ‘PrEP Gap’: how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019, „Eurosurveillance”, 24 (41), 2019, s. 1900598, DOI: 10.2807/1560-7917.ES.2019.24.41.1900598, ISSN 1560-7917, PMID: 31615599, PMCID: PMC6794989 [dostęp 2022-03-15] (ang.).

drugs.com

Apretude Dosage Guide [online], Drugs.com [dostęp 2022-03-15] (ang.).

eurosurveillance.org

RosalieR. Hayes RosalieR. i inni, Estimating the ‘PrEP Gap’: how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019, „Eurosurveillance”, 24 (41), 2019, s. 1900598, DOI: 10.2807/1560-7917.ES.2019.24.41.1900598, ISSN 1560-7917, PMID: 31615599, PMCID: PMC6794989 [dostęp 2022-03-15] (ang.).

fda.gov

Office of theO.t. Commissioner Office of theO.t., FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic [online], FDA, 20 lutego 2020 [dostęp 2022-03-14] (ang.).
Office of theO.t. Commissioner Office of theO.t., FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention [online], FDA, 20 grudnia 2021 [dostęp 2022-03-14] (ang.).

gaystarnews.com

ShannonS. Power ShannonS., Korea has just approved PrEP but who can afford it at that price? [online], Gay Star News, 2018 [dostęp 2022-03-15] (ang.).

hiv-aids.edu.pl

Program edukacyjny - Portal edukacyjny Krajowego Centrum ds. AIDS [online], www.hiv-aids.edu.pl [dostęp 2022-03-14] .

ktomalek.pl

Truvada - ulotka (dawkowanie, zastosowanie, interakcje) - KtoMaLek.pl [online], ktomalek.pl [dostęp 2022-03-15] (pol.).

medme.pl

Truvada - ulotka, skład, dawkowanie i działanie [online], www.medme.pl [dostęp 2022-03-15] (pol.).

mp.pl

Truvada (emtrycytabina + tenofowir (dizoproksyl tenofowiru)) tabletki powlekane - działanie, dawkowanie, cena, refundacja | Medycyna Praktyczna [online], www.mp.pl [dostęp 2022-03-14] .
Descovy (emtrycytabina + tenofowir (alafenamid tenofowiru)) tabletki powlekane - działanie, dawkowanie, cena, refundacja | Medycyna Praktyczna [online], www.mp.pl [dostęp 2022-03-14] .

nih.gov

ncbi.nlm.nih.gov

Lisa A.L.A. Grohskopf Lisa A.L.A. i inni, Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States, „Journal of Acquired Immune Deficiency Syndromes (1999)”, 64 (1), 2013, s. 79–86, DOI: 10.1097/QAI.0b013e31828ece33, ISSN 1944-7884, PMID: 23466649 [dostęp 2022-03-14] .
Robert M.R.M. Grant Robert M.R.M. i inni, Preexposure chemoprophylaxis for HIV prevention in men who have sex with men, „The New England Journal of Medicine”, 363 (27), 2010, s. 2587–2599, DOI: 10.1056/NEJMoa1011205, ISSN 1533-4406, PMID: 21091279, PMCID: PMC3079639 [dostęp 2022-03-14] .
KachitK. Choopanya KachitK. i inni, Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial, „The Lancet”, 381 (9883), 2013, s. 2083–2090, DOI: 10.1016/S0140-6736(13)61127-7, ISSN 1474-547X, PMID: 23769234 [dostęp 2022-03-14] .
Jared M.J.M. Baeten Jared M.J.M. i inni, Antiretroviral Prophylaxis for HIV-1 Prevention among Heterosexual Men and Women, „The New England journal of medicine”, 367 (5), 2012, s. 399–410, DOI: 10.1056/NEJMoa1108524, ISSN 0028-4793, PMID: 22784037, PMCID: PMC3770474 [dostęp 2022-03-14] .
Michael C.M.C. Thigpen Michael C.M.C. i inni, Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana, „The New England Journal of Medicine”, 367 (5), 2012, s. 423–434, DOI: 10.1056/NEJMoa1110711, ISSN 0028-4793, PMID: 22784038 [dostęp 2022-03-14] .
Jared M.J.M. Baeten Jared M.J.M. i inni, Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial, „The Lancet. Infectious Diseases”, 14 (11), 2014, s. 1055–1064, DOI: 10.1016/S1473-3099(14)70937-5, ISSN 1474-4457, PMID: 25300863, PMCID: PMC4252589 [dostęp 2022-03-14] .
JamesJ. Wilton JamesJ. i inni, Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review, „HIV/AIDS (Auckland, N.Z.)”, 7, 2015, s. 125–136, DOI: 10.2147/HIV.S50025, ISSN 1179-1373, PMID: 25987851, PMCID: PMC4422285 [dostęp 2022-03-14] .
RosalieR. Hayes RosalieR. i inni, Estimating the ‘PrEP Gap’: how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019, „Eurosurveillance”, 24 (41), 2019, s. 1900598, DOI: 10.2807/1560-7917.ES.2019.24.41.1900598, ISSN 1560-7917, PMID: 31615599, PMCID: PMC6794989 [dostęp 2022-03-15] (ang.).

dailymed.nlm.nih.gov

DailyMed - TRUVADA- emtricitabine and tenofovir disoproxil fumarate tablet, film coated [online], dailymed.nlm.nih.gov [dostęp 2022-03-15] .
DailyMed - DESCOVY- emtricitabine and tenofovir alafenamide tablet [online], dailymed.nlm.nih.gov [dostęp 2022-03-15] .

nyc.gov

www1.nyc.gov

https://www1.nyc.gov/assets/doh/downloads/pdf/imm/prep-on-demand-po.pdf (pol.)

poz.com

Canada and Israel OK Truvada as PrEP to Prevent HIV [online], POZ, 2016 [dostęp 2022-03-15] (ang.).

prep.edu.pl

PrEP [online], www.prep.edu.pl [dostęp 2022-03-14] .
PrEP [online], www.prep.edu.pl [dostęp 2022-03-14] .

ptnaids.pl

Prep [online], www.ptnaids.pl [dostęp 2022-03-15] .

skaids.org

PrEP [online], Społeczny Komitet ds. AIDS [dostęp 2022-03-14] (pol.).

starobserver.com.au

ShannonS. Power ShannonS., Norway becomes first country to offer free PrEP [online], Star Observer, 21 października 2016 [dostęp 2022-03-15] (ang.).

thesocialmedwork.com

pl.thesocialmedwork.com

Descovy [online], pl.thesocialmedwork.com [dostęp 2022-03-15] (pol.).

treated.com

pl.treated.com

Kup Truvada online I PrEP I Apteka Treated.com | Dostawa leku gratis [online], pl.treated.com [dostęp 2022-03-15] .

web.archive.org

US Public HealthU.P.H. Service US Public HealthU.P.H., PREEXPOSURE PROPHYLAXIS Preexposure prophylaxis for the prevention of HIV infection in the United States - 2014. A clinical practice guideline [online], 2014, s. 12 [zarchiwizowane z adresu 2018-04-11] .

who.int

Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Second edition, World Health Organization, 2016, s. 52, ISBN 978-92-4-154968-4 .
Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects., Genewa: World Health Organization, 2012 (ang.).

worldcat.org

Lisa A.L.A. Grohskopf Lisa A.L.A. i inni, Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States, „Journal of Acquired Immune Deficiency Syndromes (1999)”, 64 (1), 2013, s. 79–86, DOI: 10.1097/QAI.0b013e31828ece33, ISSN 1944-7884, PMID: 23466649 [dostęp 2022-03-14] .
Robert M.R.M. Grant Robert M.R.M. i inni, Preexposure chemoprophylaxis for HIV prevention in men who have sex with men, „The New England Journal of Medicine”, 363 (27), 2010, s. 2587–2599, DOI: 10.1056/NEJMoa1011205, ISSN 1533-4406, PMID: 21091279, PMCID: PMC3079639 [dostęp 2022-03-14] .
KachitK. Choopanya KachitK. i inni, Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial, „The Lancet”, 381 (9883), 2013, s. 2083–2090, DOI: 10.1016/S0140-6736(13)61127-7, ISSN 1474-547X, PMID: 23769234 [dostęp 2022-03-14] .
Jared M.J.M. Baeten Jared M.J.M. i inni, Antiretroviral Prophylaxis for HIV-1 Prevention among Heterosexual Men and Women, „The New England journal of medicine”, 367 (5), 2012, s. 399–410, DOI: 10.1056/NEJMoa1108524, ISSN 0028-4793, PMID: 22784037, PMCID: PMC3770474 [dostęp 2022-03-14] .
Michael C.M.C. Thigpen Michael C.M.C. i inni, Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana, „The New England Journal of Medicine”, 367 (5), 2012, s. 423–434, DOI: 10.1056/NEJMoa1110711, ISSN 0028-4793, PMID: 22784038 [dostęp 2022-03-14] .
Jared M.J.M. Baeten Jared M.J.M. i inni, Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial, „The Lancet. Infectious Diseases”, 14 (11), 2014, s. 1055–1064, DOI: 10.1016/S1473-3099(14)70937-5, ISSN 1474-4457, PMID: 25300863, PMCID: PMC4252589 [dostęp 2022-03-14] .
JamesJ. Wilton JamesJ. i inni, Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review, „HIV/AIDS (Auckland, N.Z.)”, 7, 2015, s. 125–136, DOI: 10.2147/HIV.S50025, ISSN 1179-1373, PMID: 25987851, PMCID: PMC4422285 [dostęp 2022-03-14] .
RosalieR. Hayes RosalieR. i inni, Estimating the ‘PrEP Gap’: how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019, „Eurosurveillance”, 24 (41), 2019, s. 1900598, DOI: 10.2807/1560-7917.ES.2019.24.41.1900598, ISSN 1560-7917, PMID: 31615599, PMCID: PMC6794989 [dostęp 2022-03-15] (ang.).